SEC Form 4 · accession 0001250853-17-000073
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy E Morris
Officer — Chief Financial Officer
Period of report
Aug 14, 2017
Accepted (ET)
Aug 16, 2017 · 2:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.05 | Aug 14, 2017 | A | 250,000 | A | — | Aug 13, 2027 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 250,000 shares shall vest on the one-year anniversary of August 14, 2017; and (ii) the remaining options shall vest as to one-twelfth of 250,000 shares at the end of each quarter over the next two years, commencing with the first quarter following the first anniversary of August 14, 2017.